These results, together with a prior report exhibiting that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 aid the idea of focusing on ACKR3 as a novel solution to modulate the opioid program, which could open new therapeutic avenues for opioid-associated disor